Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bioxyne Limited ( (AU:BXN) ) has shared an announcement.
Bioxyne Limited announced a change in the director’s interest, with Mr. Anthony Ho disposing of 1,500,000 ordinary shares valued at $43,500 through an on-market sale and reallocation between accounts. This change reflects a strategic adjustment in the director’s holdings, potentially impacting investor perceptions and market dynamics for Bioxyne’s securities.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company is known for its probiotic and immune health products, targeting both consumer and clinical markets.
Average Trading Volume: 3,873,822
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$86.59M
For detailed information about BXN stock, go to TipRanks’ Stock Analysis page.